Rui Xie
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 9
- Molecular Biology top 5%
- RNA modifications and cancer 13
- Histone Deacetylase Inhibitors Research 8
- Cancer-related gene regulation 8
- Immunology top 5%
- Biomaterials top 5%
- Oncology top 5%
- Peptidase Inhibition and Analysis 8
-
- Nanoplatforms for cancer theranostics 11
-
- Helicobacter pylori-related gastroenterology studies 8
- Journals
- Advanced Materials (1 paper)Journal of Biological Chemistry (3 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Rui Xie
140 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 1.0k
- Molecular Biology 2.3k
- Immunology 582
- Biomaterials 342
- Oncology 704
Countries citing papers authored by Rui Xie
This map shows the geographic impact of Rui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Xie more than expected).
Fields of papers citing papers by Rui Xie
This network shows the impact of papers produced by Rui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Xie. The network helps show where Rui Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 2 | |
| 12 | 2020 | 116 | |
| 13 | 2019 | 26 | |
| 14 | 2019 | 13 | |
| 15 | 2018 | 21 | |
| 16 | 2017 | 88 | |
| 17 | 2017 | 40 | |
| 18 | 2017 | 33 | |
| 19 | 2015 | 40 | |
| 20 | 2013 | 5 |
About Rui Xie
Rui Xie is a scholar working on Cancer Research, Microbiology and Molecular Medicine, having authored 146 papers that have together received 4.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers), Nanoplatforms for cancer theranostics (11 papers), MicroRNA in disease regulation (9 papers), Histone Deacetylase Inhibitors Research (8 papers), Peptidase Inhibition and Analysis (8 papers), Cancer-related gene regulation (8 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (2.3k citations) and Immunology (582 citations). Rui Xie has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shiming Yang, Piaoping Yang, Yufeng Xiao, Hui Dong, C. Hu, Lili Feng, Bo Tang, Shili Gai, Fei He and Jun Lin. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.